Emily T Martin
Overview
Explore the profile of Emily T Martin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
238
Citations
5872
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Link-Gelles R, Chickery S, Webber A, Ong T, Rowley E, DeSilva M, et al.
MMWR Morb Mortal Wkly Rep
. 2025 Feb;
74(6):73-82.
PMID: 40014628
COVID-19 vaccination averted approximately 68,000 hospitalizations during the 2023-24 respiratory season. In June 2024, CDC and the Advisory Committee on Immunization Practices (ACIP) recommended that all persons aged ≥6 months...
2.
Ibiebele J, Godonou E, Callear A, Smith M, Truscon R, Johnson E, et al.
Nat Commun
. 2025 Feb;
16(1):1249.
PMID: 39893197
The role of viral interaction-where one virus enhances or inhibits infection with another virus-in respiratory virus transmission is not well characterized. This study used data from 4029 total participants from...
3.
Huang P, Nowalk M, Zimmerman R, Olson S, Talbot H, Zhu Y, et al.
Hum Vaccin Immunother
. 2025 Jan;
21(1):2457205.
PMID: 39875316
Influenza causes 100,000-710,000 hospitalizations annually in the U.S. Patients with liver disease are at higher risk of severe outcomes following influenza infection. This study evaluated influenza vaccine effectiveness (VE) against...
4.
Feldstein L, Ruffin J, Wiegand R, Borkowf C, James-Gist J, Babu T, et al.
J Infect Dis
. 2025 Jan;
PMID: 39774936
Background: Understanding protection against SARS-CoV-2 infection by vaccine and hybrid immunity is important for informing public health strategies as new variants emerge. Methods: We analyzed data from three cohort studies...
5.
Chung J, Price A, Zimmerman R, Moehling Geffel K, House S, Curley T, et al.
Clin Infect Dis
. 2025 Jan;
PMID: 39761230
Background: The 2023-24 U.S. influenza season was characterized by a predominance of A(H1N1)pdm09 virus circulation with co-circulation of A(H3N2) and B/Victoria viruses. We estimated vaccine effectiveness (VE) in the United...
6.
Rumfelt K, Pike M, Stolarczuk J, Lekander A, Lauring A, Eckert L, et al.
Open Forum Infect Dis
. 2025 Jan;
12(1):ofae723.
PMID: 39758746
Background: Immunization against influenza and respiratory syncytial virus (RSV) protects pregnant individuals and their infants against infection via transplacental transport of immunoglobulin G (IgG). We sought to evaluate the quantity...
7.
Naraharisetti R, Trangucci R, Sakrejda K, Masters N, Malosh R, Martin E, et al.
Open Forum Infect Dis
. 2024 Dec;
12(1):ofae636.
PMID: 39720466
Disparities in coronavirus disease 2019 mortality are driven by inequalities in group-specific incidence rates (IRs), case fatality rates (CFRs), and their interaction. For emerging infections, such as severe acute respiratory...
8.
Hughes Kramer K, Zimmerman R, Haggerty C, Balasubramani G, Nowalk M, Martin E, et al.
Hum Vaccin Immunother
. 2024 Dec;
20(1):2354013.
PMID: 39693194
While the number of immunocompromised (IC) individuals continues to rise, the existing literature on influenza vaccine effectiveness (VE) in IC populations is limited. Understanding the vaccine effectiveness (VE) of the...
9.
Feldstein L, Ruffin J, Wiegand R, Grant L, Babu T, Briggs-Hagen M, et al.
J Pediatric Infect Dis Soc
. 2024 Dec;
14(1.
PMID: 39656907
To understand how coronavirus disease 2019 vaccines impact infection risk in children <5 years, we assessed risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection from September 2022 to...
10.
Bendall E, Dimcheff D, Papalambros L, Fitzsimmons W, Zhu Y, Schmitz J, et al.
bioRxiv
. 2024 Nov;
PMID: 39605326
SARS-CoV-2 has undergone repeated and rapid evolution to circumvent host immunity. However, outside of prolonged infections in immunocompromised hosts, within-host positive selection has rarely been detected. The low diversity within-hosts...